Edition:
United Kingdom

Cleveland Biolabs Inc (CBLI.OQ)

CBLI.OQ on NASDAQ Stock Exchange Capital Market

2.06USD
25 Sep 2018
Change (% chg)

$0.05 (+2.49%)
Prev Close
$2.01
Open
$2.00
Day's High
$2.06
Day's Low
$1.94
Volume
1,182
Avg. Vol
3,411
52-wk High
$4.21
52-wk Low
$1.76

Chart for

About

Cleveland BioLabs, Inc. (CBLI) is a biopharmaceutical company. The Company is engaged in developing approaches to activate the immune system and address serious medical needs. Its platform of Toll-like immune receptor activators has applications in mitigation of radiation injury and immuno-oncology. Its advanced product... (more)
No analyst recommendations are available for .

Overall

Beta: -0.19
Market Cap(Mil.): $39.37
Shares Outstanding(Mil.): 11.28
Dividend: --
Yield (%): --

Financials

  CBLI.OQ Industry Sector
P/E (TTM): -- 85.75 32.76
EPS (TTM): -0.66 -- --
ROI: -119.26 1.80 14.61
ROE: -119.07 3.29 16.33

BRIEF-Cleveland Biolabs Says Received Formal Notification From EMA

* CLEVELAND BIOLABS - RECEIVED DAY 120 REVIEW QUESTIONS FROM EMA REGARDING MARKETING AUTHORIZATION APPLICATION FOR ENTOLIMOD

28 Mar 2018

Earnings vs. Estimates